Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Dear Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of chemical active pharmaceutical ingredients (APIs) and finished drug products. Founded in 1988 and headquartered in Jinhua, Zhejiang, the company operates multiple GMP-certified production lines for tablets, capsules, and granules. Its product portfolio primarily focuses on anti-infectives, cardiovascular treatments, and gastrointestinal medications, including well-known generics like amoxicillin and omeprazole. The company serves both domestic and international markets, maintaining a strong reputation for quality and compliance in the generic drug industry. It has successfully passed numerous regulatory inspections, positioning itself as a reliable supplier of essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Dear Pharmaceutical.